Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel

NCT02388230 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT02388230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02388230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Observational
Overall status
Completed
Start date
October 31, 2015
Completion date
April 8, 2020
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast radiotherapy toxicity